Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

Drug Saf. 2020 Jun;43(6):507-509. doi: 10.1007/s40264-020-00935-2.

Italian Society of Pharmacology:
Liberato Berrino, Marzia Re, Renato Bernardini, Cristiano Chiamulera, Antonio D'Avolio, Luca Pani, Emilio Clementi, Annalisa Capuano, Francesco Scaglione, Romano Danesi, Giuseppe Cirino, Alessandro Mugelli, Giambattista Bonanno, Nicoletta Brunello, Annamaria Luca, Patrizia Hrelia, Marco Pistis, Carla Ghelardini, Maurizio Taglialatela

¹ Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy. trifirog@unime.it.
² Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
³ Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
⁴ Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
⁵ Department of Biomedical and Biotechnological Sciences, Clinical Pharmacology Unit of the University Hospital, University of Catania, Catania, Italy.

No abstract available

Publication types